What FDA's abortion pill changes mean Walgreens and CVS can now sell the abortion pill — but will they? Salon · Jan 6, 2023
UK signs groundbreaking mRNA cancer vaccine research agreement The partnership with German pharmaceutical company BioNTech will be one of the first of its kind Evening Standard · Jan 6, 2023
Structural engineers Cundall report strong year with international expansion under way The firm has delivered projects tied to the 2022 World Cup and a record-breaking rollercoaster in the Middle East Birmingham Post · Jan 6, 2023
Uzbekistan arrests four over Indian cough syrup deaths Uzbekistan has arrested four people in an investigation into the deaths of 19 children who consumed cough syrup made by Indian drug maker Marion Biotech, the Uzbek state security service said on Friday. Reuters · Jan 6, 2023
2023 could be a banner year for prescription drugs There's a large pipeline of promising yet expensive drugs that could get approved. Axios · Jan 6, 2023
Pneumagen appoints new chair New hire brings more than 30 years worth of biotech industry experience Insider UK · Jan 6, 2023
NI pharmacies facing shortage of cough and cold medicines amid high levels of winter illness Pharmacies are struggling to get hold of cough and cold medicines Belfast Live · Jan 6, 2023
BioNTech signs deal with UK for personalised cancer therapies BioNTech SE has signed a deal with the UK government to enrol up to 10,000 patients in clinical trials by the end of 2030 for personalised cancer therapies, the German drug maker said. Reuters · Jan 6, 2023
38 jobs lost as ODx Innovations collapses Inverness-based medical technology firm ran out of funds and appointed administrators just before Christmas Insider UK · Jan 6, 2023
3 High-Quality Stocks That Can Help Take Your Portfolio to the Next Level With encouraging economic data discouraging investors, the market is unlikely to stabilize anytime soon. Therefore, loading up on fundamentally strong stocks AbbVie (ABBV), Gartner (IT), and Dropbox (DBX) could keep portfolios buoyant and generate alpha in an otherwise chronic bear market. Continue reading…. StockNews.com · Jan 5, 2023
Walgreens, CVS to seek certification for dispensing abortion pills Once certified, the two largest national pharmacy chains will be able to prescribe mifepristone, a pill used in medication abortions. Chicago Sun-Times · Jan 5, 2023
Time running out for national apology as survivors of catastrophic drug thalidomide left feeling 'forgotten' Amid rapidly declining health, thalidomide survivors are still waiting for a national apology after a drug that caused catastrophic birth deformities in unborn babies continued to be sold in pharmacies. ABC News · Jan 5, 2023
Government claims more than £130 million after suing pandemic gown supplier Lawyers representing Health and Social Care Secretary Steve Barclay have outlined detail of a High Court claim against PPE Medpro. The Independent UK · Jan 5, 2023
Children's Calpol 'non-existent' on some shop shelves as flu and Covid surges A warning has been issued by health chiefs with regards to low supplies of common cold and flu medicines, while pharmacists struggle to stock up on Calpol, certain painkillers and throat lozenges Chronicle Live · Jan 5, 2023
StockNews.com · Jan 5, 2023 Want Passive Income in a Bear Market? Check out This Biotech Stock With the minutes of the latest Fed meeting showing that interest rates will keep increasing this year, the economy is widely expected to enter a recession. Amid the expected downturn this year, it could be wise to buy biotech stock Gilead Sciences (GILD) due to its solid growth prospects and…
Chronicle Live · Jan 5, 2023 Tributes to North East Professor Sir Michael Rawlins who fought to protect patients from medicine side-effects Professor Sir Michael Rawlins led a long and distinguished career at the forefront of patient safety
The Guardian - UK · Jan 5, 2023 PPE Medpro: UK government alleges firm supplied defective gowns to NHS Exclusive: DHSC alleges gowns were not sterile, could not be used within NHS ‘for any purpose’, and technical labelling was ‘invalid’
Axios · Jan 5, 2023 Why we (still) can't find any children's Tylenol For months, children’s versions of Tylenol and Motrin have felt about as hard to find as a Taylor Swift concert ticket.
ABC News · Jan 5, 2023 Ballarat's new Priority Primary Care Centre is yet to relieve pressure on ED, health chief says The town's Priority Primary Care Centre is "making a real difference to emergency department demand" by seeing up to 68 patients a day, the state government says. But the local health service's chief executive disagrees.
Tribune News Service · Jan 5, 2023 Walgreens confirms plans to sell abortion pills under new FDA rules Walgreens expects to offer abortion pills after the Food and Drug Administration changed its rules for the drug.
The Guardian - UK · Jan 4, 2023 Shortage of cold medicines in UK is government’s fault, say pharmacists Pharmacy leaders cite ministers’ ‘lack of planning’ amid problems obtaining common products
Daily Mirror · Jan 4, 2023 Calpol 'non-existent' as basic medicines run low and flu, Covid and Strep A surge Health chiefs have issued a warning about low supplies of common cold and flu medicines as pharmacists struggle to get hold of Calpol, throat lozenges and some painkillers
Manchester Evening News · Jan 4, 2023 'We will have something that will do the job': Message from Greater Manchester pharmacy leader amid cold and flu medicines shortage "People have been only buying it when they need it and that's helping ease the situation."
Manchester Evening News · Jan 4, 2023 Supermarkets respond to cold and flu drugs shortage warning Members of the public have been told by leading pharmacists to not panic and that support for patients will be made available
The Independent UK · Jan 4, 2023 Oklahoma AG announces 4 new opioid settlements worth $226M Oklahoma has entered into four new settlements with opioid makers and distributors totaling more than $226 million